Invention Grant
- Patent Title: Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof
-
Application No.: US16553042Application Date: 2019-08-27
-
Publication No.: US11058676B2Publication Date: 2021-07-13
- Inventor: Martin W. Rowbottom , John Howard Hutchinson
- Applicant: PHARMAKEA, INC.
- Applicant Address: US CA San Diego
- Assignee: PHARMAKEA, INC.
- Current Assignee: PHARMAKEA, INC.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K31/47
- IPC: A61K31/47 ; A61K31/4709 ; C07D413/04 ; C07D401/12 ; A61K9/06 ; A61K9/20 ; C07D401/04 ; A61K9/14 ; C07D401/06 ; C07D215/48 ; C07D215/233 ; C07D417/04 ; A61K47/38 ; C07D215/38 ; A61K9/00 ; A61K31/4725 ; A61P7/04 ; A61P25/00 ; A61K31/496 ; A61K31/497 ; A61K31/501 ; A61K31/506 ; A61K31/53 ; A61K31/5377 ; A61K9/08
Abstract:
Described herein are compounds that are LOXL2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with LOXL2 activity.
Public/Granted literature
- US20200022972A1 QUINOLINONE LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF Public/Granted day:2020-01-23
Information query
